LANGUALESS Inc.

LANGUALESS Inc. develops innovative communication technologies that connect humans and animals, focusing on enhancing the emotional well-being of pets through advanced wearable devices. Founded in 2016 and headquartered in Tokyo, Japan, LANGUALESS Inc. specializes in unique technologies for understanding animal emotions.

The company raised JPY 100 million in venture funding in July 2019 from investors including Mistletoe and UntroD Capital. With a total of 2 deals completed, LANGUALESS is primarily focused on its flagship product, inupathy, which visualizes dogs' emotional states by analyzing heart rate variability. Langualess focuses on developing innovative communication technologies aimed at bridging the gap between humans and animals. Their flagship product, inupathy, is a unique wearable device designed to visualize the emotional state of dogs by analyzing heart rate variability.

This device operates without the need for traditional language or numerical data, relying instead on advanced algorithms to interpret the rhythm of the heartbeats. By utilizing a specialized microphone system that detects heart sounds without requiring invasive procedures such as shaving fur or applying gel, inupathy offers a non-stressful way to monitor animals' emotional well-being. Langualess markets its products primarily in Japan, with aspirations to expand into other regions where pet ownership and animal welfare are prioritized, thus catering to a growing customer base of pet owners, veterinarians, and animal welfare organizations. Langualess generates revenue through direct sales of its flagship inupathy device and potentially through partnership agreements with pet-related businesses and veterinary clinics.

The company's transaction structure is primarily B2C, selling directly to consumers through various channels, including online platforms and retail partnerships. Pricing plans for inupathy are structured to appeal to a wide range of pet owners, emphasizing the value of emotional insights into their pets’ well-being. Additionally, Langualess may explore subscription models in the future for ongoing data analytics services related to pet health and behavior, extending the value of their core products and fostering long-term relationships with customers. Specific revenue figures and transaction volumes remain undisclosed, as the company continues to focus on product development and market expansion.

In July 2019, LANGUALESS Inc. raised JPY 100 million in venture funding to support its growth initiatives. The funding will be directed towards the development of new products, including enhancements to the inupathy device and the potential launch of additional communication technologies for pets. Furthermore, LANGUALESS aims to expand its market presence beyond Japan, targeting growing pet ownership regions in Asia by 2022.

The company plans to leverage recent investments to establish partnerships with veterinary clinics and pet retailers to facilitate this expansion.